Day: November 3, 2025

The retail turnover (including VAT) of the Apranga Group amounted to EUR 34.7 million in October 2025 and increased by 4.9% compared to October 2024. The retail turnover (including VAT) of Apranga Group reached EUR 300.5 million in January-October 2025 and increased by 5.6% compared to the corresponding period of 2024. In January-October 2025, the retail turnover of Apranga Group in Lithuania increased by 7.5% year-to-year, in Latvia increased by 5.4% and decreased by -1.3% in Estonia. Currently Apranga Group operates the chain of 171 stores (103 in Lithuania, 44 in Latvia and 24 in Estonia) covering the gross area of 92.7 thousand sq. m., or by 0.8% more than a year ago. Rimantas Perveneckas„Apranga“ Group General Manager+370 5 2390801

Press ReleaseNokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to marketAI-powered receiver technology using machine learning can greatly enhance future 6G coverage, creating cost savings and accelerating time to market. The AI technology identifies and compensates for distortion in wireless signals, leading to substantial improvements in 6G uplink coverage. Nokia and Rohde & Schwarz will demonstrate the technology at the Brooklyn 6G Summit from November 5-7.3 November 2025Espoo, Finland – Nokia and the test and measurement company Rohde & Schwarz have created and successfully tested a 6G radio receiver that uses AI technologies to overcome one of the biggest anticipated challenges of 6G network rollouts, coverage limitations inherent in 6G’s higher-frequency spectrum. The...

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platform EVX-04 is a therapeutic cancer vaccine candidate designed for acute myeloid leukemia New data showing EVX-04 induces strong T-cell responses and cancer cell killing will be presented at an oral session at the American Society of Hematology (ASH) Annual Meeting and Exposition in Florida on December 6, 2025 The concept behind EVX-04 is broadly applicable with potential across cancers where immunotherapies remain inadequateCOPENHAGEN, Denmark, November 3, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, expands its R&D pipeline with the addition EVX-04, an AI-designed precision...

VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company advancing critical mineral discoveries, is strategically positioned to capitalize on the explosive growth in the uranium sector as global nuclear commitments and artificial intelligence (AI) infrastructure propel demand far beyond current supply horizons. SAGA’s Double Mer Uranium Project: Large-Tonnage Potential in Labrador Amid this uranium fervor, SAGA Metals is well-positioned with its high potential Double Mer Uranium Project in Labrador, Canada—a drill-ready asset primed to contribute to North America’s critical minerals security. Located 90 km northeast of Happy Valley-Goose Bay near the prolific Central Mineral Belt (CMB), the 100%-owned project...

Findings further demonstrate the effectiveness of Roche’s approved medicines in advancing treatment standards for people with blood disorders Data from innovative pipeline signals progress toward improved outcomes in haemophilia A, lymphoma, and multiple myeloma Basel, 3 November 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, held 6-9 December 2025 in Orlando, Florida, US. “The data we will present at this year’s ASH meeting underscore our commitment to driving innovation across haematology and reflect meaningful progress towards improved treatment of multiple blood disorders,” said Levi Garraway, MD, PhD, Roche’s Chief...

SalMar presents results for the third quarter 2025 on Thursday 6 November 2025 at 08:00 CET. The presentation will be held at Grand Hotel in Oslo. Please note that the presentation will be held at Grand Hotel in Oslo, Karl Johans gate 31, and not at Hotel Continental as in previous quarterly presentations. CEO Frode Arntsen and CFO Ulrik Steinvik will be representing the company. The presentation will in addition be available on Norwegian webcast at 08:00 CET on www.salmar.no. There will be opportunity to send in questions during the Norwegian presentation. An English webcast (recording) will be available from 10:00 CET on www.salmar.no. After the presentation two group presentations will be arranged, one physical presentation in Norwegian at 12:00 CET and one digital presentation in English at 15:15 CET. For registration and dial in details,...

Press Release November 3, 2025 Shell plc Commences Any and All ExchangeOffers for Six Series of USD Notes Issued by Shell International Finance B.V. and BG Energy Capital plc Shell plc (“Shell”) (LSE: SHEL) (NYSE: SHEL) (AEX: SHELL) today announces the commencement of offers to Eligible Holders (as defined below) to exchange (the “Exchange Offers” and each, an “Exchange Offer”) any and all validly tendered (and not validly withdrawn) and accepted notes of five series of notes issued by Shell International Finance B.V. (“Shell International Finance”) (such notes, the “Shell International Finance Notes”) and one series of notes issued by BG Energy Capital plc (“BGEC”) (such notes, the “BGEC Notes” and such BGEC Notes, together with the Shell International Finance Notes, the “Old Notes”) for a combination of cash and a corresponding series...

Vilnius, Lithuania, Nov. 03, 2025 (GLOBE NEWSWIRE) — As at the end of October 2025, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 44,897,707, compared to the previously determined NAV of EUR 45,276,142 at the end of September 2025. The share price decreased to EUR 1.0725, from EUR 1.0815 at the end of September 2025. The pro-forma internal rate of return (IRR) decreased to 3.09%, compared to previously announced IRR of 3.41% at the end of September 2025. Contact person for further information: Paulius Nevinskas Manager of the Investment Company paulius.nevinskas@lordslb.lt https://lordslb.lt/tewox_bonds/

Exclusive Distribution Commemorates First AI-Generated Data-Driven Draft Coin for both College Football and E-Sports Live Jan. 11, 2026, from AT&T Stadium in Dallas, Texas PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) — via IBN — Datavault AI Inc. (Nasdaq: DVLT), a pioneer in AI-powered data valuation and tokenization, today unveiled plans for the highly anticipated Dream Bowl Draft, set to select top invitees for the Crusaders vs. Patriots matchup in the 2026 Dream Bowl presented by Scilex (Nasdaq: SCLX). This marquee event will culminate on Jan. 11, 2026, at AT&T Stadium in Dallas, Texas, where elite athletes will compete for the Dream Bowl Championship. Building on this excitement, Datavault AI will also host the professional Drone Racing and e-sports Championships, crowning the World Champion of Madden Football...